Myeloid control of dendritic cell priming after mechanical HIFU in colorectal cancer: implications for PD-1/PD-L1 blockade
Frontiers in Immunology · 2026
DOI: 10.3389/fimmu.2026.1998296 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Immunology, 2026. Verfasst von Yao Liao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Sichuan Clinical Research Center for Radiation and Therapy, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Techn…. Hauptthemen laut MEDLINE: Dendritic Cells, Colorectal Neoplasms, Immune Checkpoint Inhibitors, B7-H1 Antigen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mechanical high-intensity focused ultrasound releases tumor antigens and danger signals. It provides a potential substrate for immune checkpoint blockade. However, antigen release does not necessarily generate productive dendritic cell priming. In colorectal cancer, this transition occurs within a mucosal microenvironment shaped by epithelial barrier integrity, microbial exposure and myeloid clearance. Neutrophils can support epithelial repair or reinforce tumor-associated suppression. Macrophages remove apoptotic granulocytes and regulate inflammatory resolution. They can also restrain dendritic cell cytokine production. These context-dependent functions may determine whether mechanically released antigens initiate cytotoxic immunity or enter a nonproductive clearance response. This mini review integrates intestinal myeloid homeostasis with experimental evidence for mechanical ultrasound ablation and PD-1/PD-L1 blockade. It distinguishes antigen uptake from cross-presentation, protective resolution from tumor-permissive suppression, and colorectal evidence from observations in other tumor models. Functional dendritic cell readouts, lineage-resolved checkpoint measurements and concurrent barrier assessment provide a framework for evaluating combination therapy. The therapeutic objective is to preserve mucosal protection while sustaining antigen-specific immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sichuan Clinical Research Center for Radiation and Therapy, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China.
- Department of Oncology, Mianyang Central Hospital,School of Medicine, University of Electronic Science and Technology of China, Mianyang, China.
Zitieren
APA
Liao, Y., Yang, X., & Du, X. (2026). Myeloid control of dendritic cell priming after mechanical HIFU in colorectal cancer: implications for PD-1/PD-L1 blockade. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1998296
Vancouver
Liao Y, Yang X, Du X. Myeloid control of dendritic cell priming after mechanical HIFU in colorectal cancer: implications for PD-1/PD-L1 blockade. Frontiers in Immunology. 2026. doi:10.3389/fimmu.2026.1998296
BibTeX
@article{Liao2026,
author = {Liao, Yao and Yang, Xiyue and Du, Xiaobo},
title = {Myeloid control of dendritic cell priming after mechanical HIFU in colorectal cancer: implications for PD-1/PD-L1 blockade},
journal = {Frontiers in Immunology},
year = {2026},
doi = {10.3389/fimmu.2026.1998296}
}
EUVIMED